Yunovia’s platform technologies cover various modalities and technologies including
small molecules, immuno-cytokine biologics, microbiome therapeutics, and AI technologies,
and will ensure continuous innovation and accelerated development.

Total.6

  • Microbiome Therapeutics

    • Scientific capabilities
    • 2023.11.23

  • ReceptKine® mimics the nature of wild type cytokine

    • Scientific capabilities
    • 2023.11.17

  • DS/DP Process Development & Formulation

    • Scientific capabilities
    • 2023.11.17

  • Clinical Development

    • Scientific capabilities
    • 2023.11.17

  • New Chemical Entities

    • Scientific capabilities
    • 2023.11.17

  • AIminerTM & AIchemistTM, AI-based drug discover platform

    • Scientific capabilities
    • 2023.11.17